REGENXBIO Inc.

REGENXBIO Inc.
Stock Exchange NASDAQ Stock Market
EPS
$1.04
Market Cap
$1.74 B
Shares Outstanding
36.64 M
Public Float
33.62 M

Profile

Address
9600 Blackwell Road
Rockville Maryland 20850
United States
Employees -
Website http://www.regenxbio.com
Updated 07/08/2019
REGENXBIO, Inc. is a biotechnology company, which engages in the development, commercialization, and licensing of recombinant adeno-associated virus gene therapy. The company was founded by Kennth T. Mills and James M.

Financials

View All

Donald J. Hayden
Chairman
Kenneth T. Mills
President, Chief Executive Officer & Director